Literature DB >> 9117249

The influence of flow cytometric gating strategy on the standardization of CD34+ cell quantitation: an Australian multicenter study. Australasian BMT Scientists Study Group.

A Chang1, D D Ma.   

Abstract

The Australian Multi-centre study on CD34+ cell quantitation by flow cytometry documented, first, the extent of variation of CD34+ cell enumeration and, second, the influence of flow cytometric gating on CD34+ cell measurement. A PBSC harvest analyzed by 20 participating centers showed results ranging from 0.64% to 2.80%, with a median of 1.54% CD34+ cells. Of 20 centers, 9 obtained results within +/-10% of the median (the criteria for reproducibility suggested by the ISHAGE Guidelines). The flow cytometric gating strategy was identified as one of the major variables among the methods used. In stage 2, list mode data from two samples were analyzed by 24 Australian and overseas centers, including the authors of three published guidelines. Significantly different CD34+ results were obtained when different gating strategies were used (p < 0.006). When all the centers used the same gating strategy, the measurement of CD34+ cells fell within a narrow range, with 0-7% of results outside +/-10% of the median. However, when different gating strategies were used, the results were more widely scattered, with 17% of centers outside +/-10% of the median. This study demonstrated the potential impact of flow cytometric gating strategy on the reproducibility of CD34+ cell enumeration.

Entities:  

Mesh:

Year:  1996        PMID: 9117249     DOI: 10.1089/scd.1.1996.5.605

Source DB:  PubMed          Journal:  J Hematother        ISSN: 1061-6128


  3 in total

Review 1.  UK NEQAS for leucocyte immunophenotyping: the first 10 years.

Authors:  J T Reilly; D Barnett
Journal:  J Clin Pathol       Date:  2001-07       Impact factor: 3.411

2.  Single Versus Dual Platform Analysis for Hematopoietic Stem Cell Enumeration Using ISHAGE Protocol.

Authors:  Rahul Naithani; Nitin Dayal; Gaurav Dixit
Journal:  Indian J Hematol Blood Transfus       Date:  2016-12-01       Impact factor: 0.900

3.  Validation of the single-platform ISHAGE protocol for enumeration of CD34+ hematopoietic stem cells in umbilical cord blood in a Brazilian center.

Authors:  Carla Cristina Pedrosa de Lira de Morais; Juliana Dias Alves Pinto; Karen Wagner de Souza; Marina Izu; Luis Fernando da Silva Bouzas; Flávio Henrique Paraguassú-Braga
Journal:  Hematol Transfus Cell Ther       Date:  2020-12-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.